3% af de inkluderede patienter havde cirrose), skal telbivudin anvendes med særlig forsigtighed hos patienter med cirrose.
4 Patients with cirrhosis without decompensation Due to the limited data available (about 3% of patients enrolled had cirrhosis), telbivudine should be used with particular caution in cirrhotic patients.